- Home
- PRPH vs PMN Comparison
PRPH vs PMN Comparison
Compare PRPH & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPH
- PMN
- Stock Information
- Founded
- PRPH 1989
- PMN 2004
- Country
- PRPH United States
- PMN Canada
- Employees
- PRPH N/A
- PMN N/A
- Industry
- PRPH Biotechnology: Pharmaceutical Preparations
- PMN Pharmaceuticals and Biotechnology
- Sector
- PRPH Health Care
- PMN Health Care
- Exchange
- PRPH Nasdaq
- PMN Nasdaq
- Market Cap
- PRPH 15.2M
- PMN 17.0M
- IPO Year
- PRPH 1997
- PMN N/A
- Fundamental
- Price
- PRPH $0.37
- PMN $0.49
- Analyst Decision
- PRPH
- PMN Strong Buy
- Analyst Count
- PRPH 0
- PMN 2
- Target Price
- PRPH N/A
- PMN $4.50
- AVG Volume (30 Days)
- PRPH 4.1M
- PMN 42.3K
- Earning Date
- PRPH 08-13-2025
- PMN 08-07-2025
- Dividend Yield
- PRPH N/A
- PMN N/A
- EPS Growth
- PRPH N/A
- PMN N/A
- EPS
- PRPH N/A
- PMN N/A
- Revenue
- PRPH $5,845,000.00
- PMN N/A
- Revenue This Year
- PRPH $221.82
- PMN N/A
- Revenue Next Year
- PRPH N/A
- PMN N/A
- P/E Ratio
- PRPH N/A
- PMN N/A
- Revenue Growth
- PRPH N/A
- PMN N/A
- 52 Week Low
- PRPH $0.22
- PMN $0.47
- 52 Week High
- PRPH $4.33
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- PRPH 53.41
- PMN 43.83
- Support Level
- PRPH $0.32
- PMN $0.48
- Resistance Level
- PRPH $0.37
- PMN $0.53
- Average True Range (ATR)
- PRPH 0.03
- PMN 0.03
- MACD
- PRPH -0.00
- PMN 0.00
- Stochastic Oscillator
- PRPH 50.00
- PMN 21.29
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.